Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial (Q36368902)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial
scientific article

    Statements

    Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial (English)
    Marianne Ewertz
    Kathryn P Gray
    Meredith M Regan
    Karen N Price
    Hervé Bonnefoi
    John F Forbes
    Robert J Paridaens
    Richard D Gelber
    István Láng
    Ian E Smith
    Alan S Coates
    Henning T Mouridsen
    8 October 2012
    3967-3975

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit